Fingerprint
Dive into the research topics of 'Breast cancer after ovarian cancer in BRCA1 and BRCA2 pathogenic variant heterozygotes: lower rates for 5-years post chemotherapy'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Breast cancer after ovarian cancer in BRCA1 and BRCA2 pathogenic variant heterozygotes: lower rates for 5-years post chemotherapy
D. gareth Evans, Robert, d. Morgan, Emma j. Crosbie, Sacha j. Howell, Claire Forde, Anthony Howell, Fiona Lalloo, Emma r. Woodward
Research output: Contribution to journal › Article › peer-review